Loading…

Cannabinoid modulation of intestinal propulsion in mice

The effect of cannabinoid receptor activation and blockade on the propulsive activity in the mouse small intestine was assessed in the present study by measuring the transit of an orally administered, non-absorbable marker. The cannabinoid receptor agonist WIN 55,212-2 ( R(+)-[2,3-dihydro-5-methyl-3...

Full description

Saved in:
Bibliographic Details
Published in:European journal of pharmacology 1998-02, Vol.344 (1), p.67-69
Main Authors: Colombo, Giancarlo, Agabio, Roberta, Lobina, Carla, Reali, Roberta, Gessa, Gian Luigi
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The effect of cannabinoid receptor activation and blockade on the propulsive activity in the mouse small intestine was assessed in the present study by measuring the transit of an orally administered, non-absorbable marker. The cannabinoid receptor agonist WIN 55,212-2 ( R(+)-[2,3-dihydro-5-methyl-3[(morpholinyl)methyl]pyrrolo[1,2,3-de-1,4benzoxazin-yl]-(1-naphthalenyl)methanone mesylate) inhibited, while the selective cannabinoid CB 1 receptor antagonist SR 141716A ( N-piperidino-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-3-pyrazole-carboxamide) stimulated the marker transit. Furthermore, a per se non-effective dose of SR 141716A reversed WIN 55,212-2-induced reduction of the transit. The results of the present study suggest a role for cannabinoid CB 1 receptors in the control of propulsive activity in the mouse small intestine.
ISSN:0014-2999
1879-0712
DOI:10.1016/S0014-2999(97)01555-0